Bao Nguyen

1.7k total citations · 1 hit paper
38 papers, 1000 citations indexed

About

Bao Nguyen is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Bao Nguyen has authored 38 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 19 papers in Genetics and 16 papers in Molecular Biology. Recurrent topics in Bao Nguyen's work include Acute Myeloid Leukemia Research (21 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Bao Nguyen is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Bao Nguyen collaborates with scholars based in United States, China and Australia. Bao Nguyen's co-authors include Donald Small, Mark J. Levis, Li Li, Amy S. Duffield, John F. Carpenter, Theodore W. Randolph, Patrick A. Brown, Arun B. Dutta, Hannah Ennerfelt and Catherine R. Lammert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

Bao Nguyen

35 papers receiving 982 citations

Hit Papers

Meningeal lymphatic dysfu... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bao Nguyen United States 17 438 375 169 164 128 38 1000
Jasper Chen United States 11 433 1.0× 231 0.6× 39 0.2× 125 0.8× 169 1.3× 14 1.3k
Carlos Salvador Spain 20 517 1.2× 278 0.7× 151 0.9× 311 1.9× 303 2.4× 39 1.3k
Luís I. Sánchez-Abarca Spain 14 379 0.9× 385 1.0× 83 0.5× 248 1.5× 28 0.2× 19 1.0k
Urs H. Langen United States 6 586 1.3× 228 0.6× 59 0.3× 143 0.9× 74 0.6× 6 1.3k
S K Powers United States 12 194 0.4× 117 0.3× 93 0.6× 187 1.1× 104 0.8× 19 799
Shaheen Ahmed Pakistan 12 342 0.8× 254 0.7× 62 0.4× 214 1.3× 28 0.2× 37 816
Gabryella S. P. Santos Brazil 14 237 0.5× 128 0.3× 73 0.4× 140 0.9× 20 0.2× 23 683
Michael A. Thornton United States 16 188 0.4× 252 0.7× 126 0.7× 45 0.3× 26 0.2× 26 932
Conrad A. Messam United States 14 397 0.9× 98 0.3× 130 0.8× 230 1.4× 70 0.5× 20 952
Ken Morii Japan 17 233 0.5× 70 0.2× 73 0.4× 220 1.3× 147 1.1× 54 742

Countries citing papers authored by Bao Nguyen

Since Specialization
Citations

This map shows the geographic impact of Bao Nguyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bao Nguyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bao Nguyen more than expected).

Fields of papers citing papers by Bao Nguyen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bao Nguyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bao Nguyen. The network helps show where Bao Nguyen may publish in the future.

Co-authorship network of co-authors of Bao Nguyen

This figure shows the co-authorship network connecting the top 25 collaborators of Bao Nguyen. A scholar is included among the top collaborators of Bao Nguyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bao Nguyen. Bao Nguyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, S. D., Casey J. N. Mathison, Shanshan Yan, et al.. (2025). Triggering AHR resolves TGF-β1 induced fibroblast activation and promotes AT1 cell regeneration in alveolar organoids. Communications Biology. 8(1). 1025–1025.
2.
Chu, S. Haihua, Li Li, Bao Nguyen, et al.. (2024). Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition. Leukemia. 38(7). 1581–1591.
3.
Zheng, Mingjie, Gang Li, Jia Song, et al.. (2022). Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis. Circulation. 146(22). 1694–1711. 18 indexed citations
4.
Yoon, Sung-Soo, Dong‐Yeop Shin, Je‐Hwan Lee, et al.. (2022). A Potent Small Molecule Inhibitor of FLT3, PHI-101 Overcomes Resistance in Acute Myeloid Leukemia: Efficacy and PK/PD Profile in Phase 1 First in Human Study. Blood. 140(Supplement 1). 3365–3366. 3 indexed citations
5.
Zhao, Xiaolei, Li Tang, Bao Nguyen, et al.. (2022). Yap and Taz promote osteogenesis and prevent chondrogenesis in neural crest cells in vitro and in vivo. Science Signaling. 15(757). eabn9009–eabn9009. 27 indexed citations
6.
Young, David J., Bao Nguyen, Li Li, et al.. (2021). A Method for Overcoming Plasma Protein Inhibition of Tyrosine Kinase Inhibitors. Blood Cancer Discovery. 2(5). 532–547. 7 indexed citations
7.
Liu, Shijie, Li Tang, Xiaolei Zhao, et al.. (2021). Yap Promotes Noncanonical Wnt Signals From Cardiomyocytes for Heart Regeneration. Circulation Research. 129(8). 782–797. 45 indexed citations
8.
Li, Li, Bao Nguyen, Jaesung Seo, et al.. (2021). FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation. Signal Transduction and Targeted Therapy. 6(1). 186–186. 69 indexed citations
9.
Young, David J., Bao Nguyen, Jaesung Seo, et al.. (2021). Deletions in FLT-3 juxtamembrane domain define a new class of pathogenic mutations: case report and systematic analysis. Blood Advances. 5(9). 2285–2293. 11 indexed citations
10.
Bolte, Ashley C., Arun B. Dutta, Igor Smirnov, et al.. (2020). Meningeal lymphatic dysfunction exacerbates traumatic brain injury pathogenesis. Nature Communications. 11(1). 4524–4524. 242 indexed citations breakdown →
11.
Nguyen, Bao, Mamoru Ishii, Robert E. Maxson, & Jun Wang. (2018). Culturing and Manipulation of O9-1 Neural Crest Cells. Journal of Visualized Experiments. 12 indexed citations
12.
Nguyen, Bao, David J. Young, Hayley Ma, et al.. (2017). FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors. Oncotarget. 8(7). 10931–10944. 33 indexed citations
13.
Gerhardt, Alana, Bao Nguyen, Rachael A. Lewus, John F. Carpenter, & Theodore W. Randolph. (2015). Effect of the Siliconization Method on Particle Generation in a Monoclonal Antibody Formulation in Pre-filled Syringes. Journal of Pharmaceutical Sciences. 104(5). 1601–1609. 42 indexed citations
14.
Gerhardt, Alana, Bao Nguyen, Rachael A. Lewus, et al.. (2015). Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes. Journal of Pharmaceutical Sciences. 104(12). 4056–4064. 46 indexed citations
15.
Hayley, S., Bao Nguyen, Amy S. Duffield, et al.. (2014). FLT3 Kinase Inhibitor TTT-3002 Overcomes Both Activating and Drug Resistance Mutations in FLT3 in Acute Myeloid Leukemia. Cancer Research. 74(18). 5206–5217. 25 indexed citations
16.
Greenblatt, Sarah, Li Li, Christopher Slape, et al.. (2012). Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model. Blood. 119(12). 2883–2894. 49 indexed citations
17.
Nguyen, Bao, et al.. (2012). Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors. Leukemia. 27(1). 48–55. 79 indexed citations
18.
Zheng, Rui, Bao Nguyen, Xiaochuan Yang, et al.. (2011). Further activation of FLT3 mutants by FLT3 ligand. Oncogene. 30(38). 4004–4014. 42 indexed citations
19.
Greenblatt, Sarah, Li Li, Christopher Slape, et al.. (2011). Knock-in of a FLT3 Internal Tandem Duplication Mutation Cooperates with a NUP98-HOXD13 Fusion to Generate Acute Myeloid Leukemia. Blood. 118(21). 865–865.
20.
Piloto, Obdulio, Patrick A. Brown, Li Li, et al.. (2004). EB10, an Anti-FLT3 Monoclonal Antibody, Selectively Targets ALL Cell Lines and Primary ALL Blasts without Interfering with Normal Hematopoiesis.. Blood. 104(11). 2744–2744. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026